医学
打开标签
眼科
临床试验
临床研究阶段
外科
内科学
作者
Pedram Hamrah,Mina Massaro‐Giordano,David J. Schanzlin,Edward J. Holland,Gregg J. Berdy,Giovanni Goisis,Georgea Pasedis,Flavio Mantelli
标识
DOI:10.1007/s40123-023-00866-y
摘要
Cenegermin is approved for treatment of neurotrophic keratopathy (NK) and has been studied in patients with stage 2 or 3 NK. This study evaluated the efficacy and safety of cenegermin in adults with stage 1 NK.
科研通智能强力驱动
Strongly Powered by AbleSci AI